首页 > 最新文献

Biomedicine Hub最新文献

英文 中文
Tattoo-Associated Basal Cell Carcinoma: Coincident or Coincidence. 纹身相关基底细胞癌:巧合还是巧合。
Pub Date : 2020-07-08 eCollection Date: 2020-05-01 DOI: 10.1159/000508208
Philip R Cohen, Christof P Erickson, Nathan S Uebelhoer, Antoanella Calame

Tattoos may be associated with medical complications including, albeit rarely, skin cancer. The features of a 46-year-old man who developed a basal cell carcinoma within a tattoo on his left scapula are described and the characteristics of the other 13 patients (7 men and 6 women) with tattoo-associated basal cell carcinoma are reviewed. The tumor usually occurs on the sun-exposed skin of individuals aged 60 years and older whose tattoo has often been present for 20 years or more. The pathogenesis of a basal cell carcinoma developing within a tattoo may merely be a coincidence. However, there is supporting evidence that the tattoo and the subsequent basal cell carcinoma may be coincident events whereby either tattoo injection-associated trauma or the tattoo pigments and dyes (in their native state or after ultraviolet radiation alteration) or both have a carcinogenic impact on the development of the basal cell carcinoma at that location.

纹身可能与医学并发症有关,包括皮肤癌,尽管很少。本文描述了一名46岁男性在其左肩胛骨纹身内发生基底细胞癌的特征,并回顾了其他13名纹身相关基底细胞癌患者(7男6女)的特征。这种肿瘤通常发生在60岁及以上的人暴露在阳光下的皮肤上,他们的纹身通常已经存在了20年或更长时间。基底细胞癌在纹身内发展的发病机制可能仅仅是一个巧合。然而,有支持证据表明,纹身和随后的基底细胞癌可能是巧合事件,纹身注射相关的创伤或纹身色素和染料(在其天然状态或经过紫外线辐射改变后)或两者都对该部位的基底细胞癌的发展有致癌影响。
{"title":"Tattoo-Associated Basal Cell Carcinoma: Coincident or Coincidence.","authors":"Philip R Cohen,&nbsp;Christof P Erickson,&nbsp;Nathan S Uebelhoer,&nbsp;Antoanella Calame","doi":"10.1159/000508208","DOIUrl":"https://doi.org/10.1159/000508208","url":null,"abstract":"<p><p>Tattoos may be associated with medical complications including, albeit rarely, skin cancer. The features of a 46-year-old man who developed a basal cell carcinoma within a tattoo on his left scapula are described and the characteristics of the other 13 patients (7 men and 6 women) with tattoo-associated basal cell carcinoma are reviewed. The tumor usually occurs on the sun-exposed skin of individuals aged 60 years and older whose tattoo has often been present for 20 years or more. The pathogenesis of a basal cell carcinoma developing within a tattoo may merely be a coincidence. However, there is supporting evidence that the tattoo and the subsequent basal cell carcinoma may be coincident events whereby either tattoo injection-associated trauma or the tattoo pigments and dyes (in their native state or after ultraviolet radiation alteration) or both have a carcinogenic impact on the development of the basal cell carcinoma at that location.</p>","PeriodicalId":9075,"journal":{"name":"Biomedicine Hub","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000508208","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38440743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Risk Factors for Delayed Surgical Recovery and Massive Bleeding in Skull Base Surgery. 颅底手术中延迟手术恢复和大出血的风险因素。
Pub Date : 2020-07-07 eCollection Date: 2020-05-01 DOI: 10.1159/000507750
Kenya Kobayashi, Fumihiko Matsumoto, Yasuji Miyakita, Masaki Arikawa, Go Omura, Satoko Matsumura, Atsuo Ikeda, Azusa Sakai, Kohtaro Eguchi, Yoshitaka Narita, Satoshi Akazawa, Shimpei Miyamoto, Seiichi Yoshimoto

Background: To determine factors that delay surgical recovery and increase intraoperative hemorrhage in skull base surgery.

Methods: Factors related to delayed postoperative recovery were retrospectively reviewed in 33 patients who underwent open skull base surgery. Early and late recovery phases were assessed as "days required to walk around the ward (DWW)" and "length of hospital stay (LHS)," respectively. Intraoperative blood loss was cal-culated every hour and analyzed in 4 steps, i.e., craniotomy and intracranial manipulation, cranial fossa osteotomy, extracranial osteotomy, and reconstruction.

Results: More than 4,000 mL of blood loss (B = 2.7392, Exp[B] = 15.4744; 95% CI 1.1828-202.4417) and comorbidi-ty (B = 2.3978, Exp[B]) = 10.9987; 95% CI 1.3534-98.3810) significantly prolonged the DWW; the occurrence of postoperative complications significantly delayed the LHS (p = 0.0316). Tumor invasion to the hard palate, the maxillary sinus, the pterygopalatine fossa, the base of the pterygoid process, the sphenoid sinus, the middle cranial fossa, and the cavernous sinus and a long operation time (>13 h) were associated with increased total hemorrhage. The optimal cut-off hemorrhage volume associated with total massive blood loss in craniotomy and intracranial manipulation (AUC = 0.8364), cranial fossa osteotomy (AUC = 0.8000), and extracranial osteotomy (AUC = 0.8545) was 1,111, 750, and 913 mL, respectively. Persistent infection (6%) and neuropsychiatric disorder (6%) are direct causes of delayed LHS.

Conclusion: Blood loss, comorbidity, and postoperative complications were risk factors for delayed surgical recovery. Meticulous preoperative planning, intraoperative surefire hemostasis, and perioperative holistic management are prerequisites for safe skull base surgery.

背景: 确定颅底手术中延迟手术恢复和增加术中出血的因素:目的:确定颅底手术中延迟手术恢复和增加术中出血的因素:方法:对 33 名接受开放性颅底手术的患者进行了术后恢复延迟相关因素的回顾性研究。早期和晚期恢复阶段分别以 "在病房行走所需天数(DWW)"和 "住院时间(LHS)"进行评估。每小时对术中失血量进行计算,并按开颅和颅内操作、颅窝截骨、颅外截骨和重建4个步骤进行分析:失血量超过 4000 毫升(B = 2.7392,Exp[B] = 15.4744;95% CI 1.1828-202.4417)和合并症(B = 2.3978,Exp[B]) = 10.9987;95% CI 1.3534-98.3810)显著延长了 DWW;术后并发症的发生显著延迟了 LHS(P = 0.0316)。肿瘤侵犯硬腭、上颌窦、翼腭窝、翼突基底、鼻窦、中颅窝和海绵窦以及手术时间过长(>13 h)与总出血量增加有关。在开颅手术和颅内操作(AUC = 0.8364)、颅窝截骨术(AUC = 0.8000)和颅外截骨术(AUC = 0.8545)中,与总大量失血相关的最佳截断出血量分别为1,111、750和913毫升。持续感染(6%)和神经精神障碍(6%)是导致LHS延迟的直接原因:结论:失血、合并症和术后并发症是导致手术恢复延迟的风险因素。缜密的术前计划、术中万无一失的止血以及围手术期的整体管理是安全进行颅底手术的先决条件。
{"title":"Risk Factors for Delayed Surgical Recovery and Massive Bleeding in Skull Base Surgery.","authors":"Kenya Kobayashi, Fumihiko Matsumoto, Yasuji Miyakita, Masaki Arikawa, Go Omura, Satoko Matsumura, Atsuo Ikeda, Azusa Sakai, Kohtaro Eguchi, Yoshitaka Narita, Satoshi Akazawa, Shimpei Miyamoto, Seiichi Yoshimoto","doi":"10.1159/000507750","DOIUrl":"10.1159/000507750","url":null,"abstract":"<p><strong>Background: </strong>To determine factors that delay surgical recovery and increase intraoperative hemorrhage in skull base surgery.</p><p><strong>Methods: </strong>Factors related to delayed postoperative recovery were retrospectively reviewed in 33 patients who underwent open skull base surgery. Early and late recovery phases were assessed as \"days required to walk around the ward (DWW)\" and \"length of hospital stay (LHS),\" respectively. Intraoperative blood loss was cal-culated every hour and analyzed in 4 steps, i.e., craniotomy and intracranial manipulation, cranial fossa osteotomy, extracranial osteotomy, and reconstruction.</p><p><strong>Results: </strong>More than 4,000 mL of blood loss (<i>B</i> = 2.7392, Exp[<i>B</i>] = 15.4744; 95% CI 1.1828-202.4417) and comorbidi-ty (<i>B</i> = 2.3978, Exp[<i>B</i>]) = 10.9987; 95% CI 1.3534-98.3810) significantly prolonged the DWW; the occurrence of postoperative complications significantly delayed the LHS (<i>p</i> = 0.0316). Tumor invasion to the hard palate, the maxillary sinus, the pterygopalatine fossa, the base of the pterygoid process, the sphenoid sinus, the middle cranial fossa, and the cavernous sinus and a long operation time (>13 h) were associated with increased total hemorrhage. The optimal cut-off hemorrhage volume associated with total massive blood loss in craniotomy and intracranial manipulation (AUC = 0.8364), cranial fossa osteotomy (AUC = 0.8000), and extracranial osteotomy (AUC = 0.8545) was 1,111, 750, and 913 mL, respectively. Persistent infection (6%) and neuropsychiatric disorder (6%) are direct causes of delayed LHS.</p><p><strong>Conclusion: </strong>Blood loss, comorbidity, and postoperative complications were risk factors for delayed surgical recovery. Meticulous preoperative planning, intraoperative surefire hemostasis, and perioperative holistic management are prerequisites for safe skull base surgery.</p>","PeriodicalId":9075,"journal":{"name":"Biomedicine Hub","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392383/pdf/bmh-0005-0991.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38256668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Magnification Effect of Foveal Avascular Zone Measurement Using Optical Coherence Tomography Angiography. 光学相干断层血管造影测量中央凹无血管区的放大效应。
Pub Date : 2020-06-12 eCollection Date: 2020-05-01 DOI: 10.1159/000507501
Mika Suda, Yuji Yoshikawa, Gaku Terauchi, Soiti Matsumoto, Takuhei Shoji, Kei Shinoda, Atsushi Mizota, Yoshiharu Kobayashi

Purpose: The aim of this study was to evaluate the foveal avascular zone (FAZ) of healthy subjects and examine the magnification effect.

Methods: A total of 33 healthy volunteers were enrolled and all subjects were eligible for analysis. Optical coherence tomography angiography (OCTA) examination scanned 3 × 3 mm of the macular area. The FAZ area was measured on the superficial OCTA en face image with and without correction by axial length. The relationship between changes in the FAZ area after correction with the axial length was examined.

Results: The mean age was 21.9 ± 0.6 years. The mean axial length was 24.87 ± 1.17 mm and mean spherical equivalent (SE) value was -3.64 ± 2.83 diopters (D). The FAZ area was 0.26 ± 0.10 mm2 before the axial length correction and 0.27 ± 0.10 mm2 after the correction. In the eyes that had an axial length longer than or equal to 26 mm or SE less than or equal to -6 D, the FAZ area after correction was significantly larger than that before correction (p < 0.01). The change of FAZ area after correction with axial length was significantly correlated with the axial length (R 2 = 0.88, p < 0.01) or SE value (R 2 = 0.55, p < 0.01).

Conclusion: FAZ areas were comparable to previous reports. In high myopic cases, the magnification effect needs to be considered when evaluating the FAZ area.

目的:评价健康受试者的中央凹无血管带(FAZ),并考察其放大效果。方法:共纳入33名健康志愿者,所有受试者均符合分析条件。光学相干断层血管造影(OCTA)检查扫描黄斑区域3 × 3 mm。在经过轴向长度校正和未经过轴向长度校正的表面OCTA面部图像上测量FAZ面积。分析了校正后FAZ面积的变化与轴向长度的关系。结果:患者平均年龄21.9±0.6岁。平均轴长为24.87±1.17 mm,平均球面等效(SE)值为-3.64±2.83屈光度(D),轴长校正前的FAZ面积为0.26±0.10 mm2,校正后的FAZ面积为0.27±0.10 mm2。眼轴长大于等于26 mm或SE小于等于-6 D的眼,矫正后FAZ面积明显大于矫正前(p < 0.01)。校正后FAZ面积随轴向长度的变化与轴向长度(r2 = 0.88, p < 0.01)或SE值(r2 = 0.55, p < 0.01)显著相关。结论:FAZ区域与以往报道相当。在高度近视的情况下,评估FAZ区域时需要考虑放大效应。
{"title":"Magnification Effect of Foveal Avascular Zone Measurement Using Optical Coherence Tomography Angiography.","authors":"Mika Suda,&nbsp;Yuji Yoshikawa,&nbsp;Gaku Terauchi,&nbsp;Soiti Matsumoto,&nbsp;Takuhei Shoji,&nbsp;Kei Shinoda,&nbsp;Atsushi Mizota,&nbsp;Yoshiharu Kobayashi","doi":"10.1159/000507501","DOIUrl":"https://doi.org/10.1159/000507501","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to evaluate the foveal avascular zone (FAZ) of healthy subjects and examine the magnification effect.</p><p><strong>Methods: </strong>A total of 33 healthy volunteers were enrolled and all subjects were eligible for analysis. Optical coherence tomography angiography (OCTA) examination scanned 3 × 3 mm of the macular area. The FAZ area was measured on the superficial OCTA en face image with and without correction by axial length. The relationship between changes in the FAZ area after correction with the axial length was examined.</p><p><strong>Results: </strong>The mean age was 21.9 ± 0.6 years. The mean axial length was 24.87 ± 1.17 mm and mean spherical equivalent (SE) value was -3.64 ± 2.83 diopters (D). The FAZ area was 0.26 ± 0.10 mm<sup>2</sup> before the axial length correction and 0.27 ± 0.10 mm<sup>2</sup> after the correction. In the eyes that had an axial length longer than or equal to 26 mm or SE less than or equal to -6 D, the FAZ area after correction was significantly larger than that before correction (<i>p</i> < 0.01). The change of FAZ area after correction with axial length was significantly correlated with the axial length (<i>R</i> <sup>2</sup> = 0.88, <i>p</i> < 0.01) or SE value (<i>R</i> <sup>2</sup> = 0.55, <i>p</i> < 0.01).</p><p><strong>Conclusion: </strong>FAZ areas were comparable to previous reports. In high myopic cases, the magnification effect needs to be considered when evaluating the FAZ area.</p>","PeriodicalId":9075,"journal":{"name":"Biomedicine Hub","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000507501","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38256667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
A Case of External Auditory Canal Sebaceous Carcinoma: Literature Review and Treatment Discussion. 外耳道皮脂腺癌1例:文献复习及治疗探讨。
Pub Date : 2020-06-11 eCollection Date: 2020-05-01 DOI: 10.1159/000508058
Robert Saadi, Michael Pennock, Aaron Baker, Huseyin Isildak

Sebaceous neoplasms are a rare type of skin cancer that may occur in any area with sebaceous glands, including the outer third of the external auditory canal. However, documentation of the tumor originating in this location is limited to scarce case reports. In this location, malignancies can invade the temporal bone, typically requiring en bloc resection and radiation therapy. We describe a case managed with limited surgical excision based on criteria for primary squamous cell carcinoma of the external auditory canal with only close observation following surgery. Margins were free of disease following excision and histology demonstrated a favorable prognosis. The patient was disease free after a follow-up period of over 3 years postoperatively. A review of relevant literature is utilized to discuss clinical characteristics, staging, treatment, and prognosis to assist in clinical decision making for these patients.

皮脂腺肿瘤是一种罕见的皮肤癌,可发生在皮脂腺的任何部位,包括外耳道的外三分之一。然而,关于肿瘤起源于该部位的文献报道很少。在这个位置,恶性肿瘤可以侵入颞骨,通常需要整体切除和放射治疗。我们描述了一例基于外耳道原发性鳞状细胞癌标准的有限手术切除,手术后仅密切观察。切除后边缘无病变,组织学显示预后良好。术后随访3年以上,患者无疾病。通过对相关文献的回顾,探讨这些患者的临床特征、分期、治疗和预后,以协助临床决策。
{"title":"A Case of External Auditory Canal Sebaceous Carcinoma: Literature Review and Treatment Discussion.","authors":"Robert Saadi,&nbsp;Michael Pennock,&nbsp;Aaron Baker,&nbsp;Huseyin Isildak","doi":"10.1159/000508058","DOIUrl":"https://doi.org/10.1159/000508058","url":null,"abstract":"<p><p>Sebaceous neoplasms are a rare type of skin cancer that may occur in any area with sebaceous glands, including the outer third of the external auditory canal. However, documentation of the tumor originating in this location is limited to scarce case reports. In this location, malignancies can invade the temporal bone, typically requiring en bloc resection and radiation therapy. We describe a case managed with limited surgical excision based on criteria for primary squamous cell carcinoma of the external auditory canal with only close observation following surgery. Margins were free of disease following excision and histology demonstrated a favorable prognosis. The patient was disease free after a follow-up period of over 3 years postoperatively. A review of relevant literature is utilized to discuss clinical characteristics, staging, treatment, and prognosis to assist in clinical decision making for these patients.</p>","PeriodicalId":9075,"journal":{"name":"Biomedicine Hub","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000508058","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38256663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
COVID-19: How to Use a Jet Nebulizer for Drug Administration in Ventilated Patients without Putting the Healthcare Workers at Risk. COVID-19:如何在不危及医护人员的情况下使用喷射雾化器给药通气患者。
Pub Date : 2020-06-02 eCollection Date: 2020-05-01 DOI: 10.1159/000508845
Arieh Eden, Tzipora Gashi, Irina Bergman, Dmitry Kompaniets, Avinoam Shiran
Dear Editor, A jet nebulizer is frequently used in ventilated patients to administer inhalations with bronchodilators and hypertonic saline. In ventilated COVID-19 patients, this can be beneficial to reduce airway blockage with viscous secretions and to decrease the need for bronchoscopy due to airway obstruction. However, the use of a nebulizer requires frequent disconnections of the ventilator circuit. In ventilated COVID-19 patients, this action can greatly increase the risk of airborne infection for healthcare workers through aerosol formation. The SARS-CoV-2 virus can remain viable and infectious in aerosols for hours [1]. It has been recommended that nebulization of medications should be avoided in ventilated COVID-19 patients to reduce the risk of infection for healthcare workers [2]. Usually, the use of a nebulizer requires disconnection of the heat and moisture exchanger (HME) filter (located between the endotracheal tube and the ventilator circuit) and the nebulizer itself for each inhalation (Fig. 1, showing standard configuration). We propose using a one-way valve (BTS1241A; WILAmed GmbH, Kammerstein, Germany) in the nebulizer T-piece (Fig. 2), which will enable disconnection of the nebulizer cup for medication loading Received: April 30, 2020 Accepted: May 22, 2020 Published online: June 2, 2020
{"title":"COVID-19: How to Use a Jet Nebulizer for Drug Administration in Ventilated Patients without Putting the Healthcare Workers at Risk.","authors":"Arieh Eden,&nbsp;Tzipora Gashi,&nbsp;Irina Bergman,&nbsp;Dmitry Kompaniets,&nbsp;Avinoam Shiran","doi":"10.1159/000508845","DOIUrl":"https://doi.org/10.1159/000508845","url":null,"abstract":"Dear Editor, A jet nebulizer is frequently used in ventilated patients to administer inhalations with bronchodilators and hypertonic saline. In ventilated COVID-19 patients, this can be beneficial to reduce airway blockage with viscous secretions and to decrease the need for bronchoscopy due to airway obstruction. However, the use of a nebulizer requires frequent disconnections of the ventilator circuit. In ventilated COVID-19 patients, this action can greatly increase the risk of airborne infection for healthcare workers through aerosol formation. The SARS-CoV-2 virus can remain viable and infectious in aerosols for hours [1]. It has been recommended that nebulization of medications should be avoided in ventilated COVID-19 patients to reduce the risk of infection for healthcare workers [2]. Usually, the use of a nebulizer requires disconnection of the heat and moisture exchanger (HME) filter (located between the endotracheal tube and the ventilator circuit) and the nebulizer itself for each inhalation (Fig. 1, showing standard configuration). We propose using a one-way valve (BTS1241A; WILAmed GmbH, Kammerstein, Germany) in the nebulizer T-piece (Fig. 2), which will enable disconnection of the nebulizer cup for medication loading Received: April 30, 2020 Accepted: May 22, 2020 Published online: June 2, 2020","PeriodicalId":9075,"journal":{"name":"Biomedicine Hub","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000508845","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38169341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Propelling Health Care into the Twenties. 推动医疗保健进入二十年代。
Pub Date : 2020-05-27 eCollection Date: 2020-05-01 DOI: 10.1159/000508300
Denis Horgan, Bettina Borisch, Etienne Richer, Chiara Bernini, Dipak Kalra, Mark Lawler, Gennaro Ciliberto, Hendrik Van Poppel, Angelo Paradiso, Peter Riegman, Stefano Triberti, Andres Metspalu, Arturo Chiti, Elizabeth Macintyre, Stefania Boccia, Fabien Calvo, Desmond Schatz, Jasmina Koeva-Balabanova, Bengt Jonsson

The scope and potential of personalised health care are underappreciated and underrealised, often because of resistance to change. The consequence is that many inadequacies of health care in Europe persist unnecessarily, and many opportunities for improvement are neglected. This article identifies the principal challenges, outlines possible approaches to resolving them, and highlights the benefits that could result from greater adoption of personalised health care. It locates the discussion in the context of European policy, focusing particularly on the most recent and authoritative reviews of health care in the EU Member States, and on the newly acquired spirit of readiness and pragmatism among European officials to embrace change and innovative technologies in a new decade. It highlights the attention now being given by policymakers to incentives, innovation, and investment as levers to improve European citizens' prospects in a rapidly evolving world, and how these distinct and disruptive themes contribute to a renaissance in thinking about delivering optimal health care in Europe. It explores the chances offered to patients by specific initiatives in health domains such as cancer and antimicrobial resistance, and by innovative science, novel therapies, earlier diagnosis tools, and deeper understanding of health promotion and prevention. And it reflects on how health care providers could benefit from a shift towards better primary care and towards deploying health data more effectively, including the use of artificial intelligence, coupled with a move to a smoother organisational/regulatory structure and realigned professional responsibilities. The conclusion is that preparing Europe's health care systems for the inevitable strains of the coming years is both possible and necessary. A more courageous approach to embracing personalised health care could guarantee the sustainability of Europe's health care systems before rising demands and exponential costs overwhelm them - an exercise in future-proofing, in ensuring that they are equipped to withstand whatever lies ahead. A focus on the potential and implementation of personalised care would permit more efficient use of resources and deliver better quality health-preserving care.

个性化医疗保健的范围和潜力未得到充分的重视和实现,这往往是由于对变革的抵制。其后果是,欧洲医疗保健的许多不足之处被不必要地保留了下来,许多改进的机会也被忽视了。本文指出了主要的挑战,概述了解决这些挑战的可能方法,并强调了更多采用个性化医疗服务可能带来的益处。文章将讨论置于欧洲政策的背景下,特别关注欧盟成员国最近对医疗保健进行的权威性审查,以及欧洲官员在新的十年中为迎接变革和创新技术而新近获得的准备就绪和务实精神。该书强调了政策制定者目前对激励、创新和投资的关注,将其作为在快速发展的世界中改善欧洲公民前景的杠杆,以及这些独特和颠覆性的主题如何促进欧洲提供最佳医疗服务的思维复兴。报告探讨了癌症和抗菌药耐药性等健康领域的具体举措,以及创新科学、新型疗法、早期诊断工具和对健康促进与预防的深入理解为患者提供的机会。报告还反思了医疗服务提供者如何才能受益于向更好的初级保健和更有效地部署健康数据(包括使用人工智能)的转变,以及向更顺畅的组织/监管结构和重新调整的专业职责的转变。结论是,让欧洲的医疗系统做好准备,应对未来几年不可避免的压力,既是可能的,也是必要的。以更大胆的方式接受个性化医疗服务,可以在不断增长的需求和成倍增加的成本将欧洲医疗系统压垮之前,保证其可持续性--这是一项面向未来的工作,以确保医疗系统有能力承受未来的一切。关注个性化医疗的潜力和实施,可以更有效地利用资源,提供更优质的医疗保健服务。
{"title":"Propelling Health Care into the Twenties.","authors":"Denis Horgan, Bettina Borisch, Etienne Richer, Chiara Bernini, Dipak Kalra, Mark Lawler, Gennaro Ciliberto, Hendrik Van Poppel, Angelo Paradiso, Peter Riegman, Stefano Triberti, Andres Metspalu, Arturo Chiti, Elizabeth Macintyre, Stefania Boccia, Fabien Calvo, Desmond Schatz, Jasmina Koeva-Balabanova, Bengt Jonsson","doi":"10.1159/000508300","DOIUrl":"10.1159/000508300","url":null,"abstract":"<p><p>The scope and potential of personalised health care are underappreciated and underrealised, often because of resistance to change. The consequence is that many inadequacies of health care in Europe persist unnecessarily, and many opportunities for improvement are neglected. This article identifies the principal challenges, outlines possible approaches to resolving them, and highlights the benefits that could result from greater adoption of personalised health care. It locates the discussion in the context of European policy, focusing particularly on the most recent and authoritative reviews of health care in the EU Member States, and on the newly acquired spirit of readiness and pragmatism among European officials to embrace change and innovative technologies in a new decade. It highlights the attention now being given by policymakers to incentives, innovation, and investment as levers to improve European citizens' prospects in a rapidly evolving world, and how these distinct and disruptive themes contribute to a renaissance in thinking about delivering optimal health care in Europe. It explores the chances offered to patients by specific initiatives in health domains such as cancer and antimicrobial resistance, and by innovative science, novel therapies, earlier diagnosis tools, and deeper understanding of health promotion and prevention. And it reflects on how health care providers could benefit from a shift towards better primary care and towards deploying health data more effectively, including the use of artificial intelligence, coupled with a move to a smoother organisational/regulatory structure and realigned professional responsibilities. The conclusion is that preparing Europe's health care systems for the inevitable strains of the coming years is both possible and necessary. A more courageous approach to embracing personalised health care could guarantee the sustainability of Europe's health care systems before rising demands and exponential costs overwhelm them - an exercise in future-proofing, in ensuring that they are equipped to withstand whatever lies ahead. A focus on the potential and implementation of personalised care would permit more efficient use of resources and deliver better quality health-preserving care.</p>","PeriodicalId":9075,"journal":{"name":"Biomedicine Hub","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392387/pdf/bmh-0005-0001.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38256669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variations in the Management of Cervical Thoracic Duct Cyst. 颈胸导管囊肿的不同处理方法。
Pub Date : 2020-05-12 eCollection Date: 2020-05-01 DOI: 10.1159/000507275
Edgardo Abelardo, Priyanka Shastri, Vinod Prabhu

We present an uncomplicated case report of a cervical thoracic duct cyst (CTDC) in a 61-year-old woman treated with surgical excision. We reviewed 47 similar cases since it was first described in 1964 and evaluated the different diagnostic and management approaches. Previously believed to be the gold standard tool for evaluation, lymphangiography is now less popular due to advent of high-resolution imaging combined with aspiration techniques. CTDC treatment includes observation, low-fat diet, repeated aspirations, external pressure, sclerotherapy, embolisation, and surgical intervention. The preferred management of choice to date is surgical excision.

我们提出一个简单的病例报告颈胸导管囊肿(CTDC)在61岁的妇女治疗手术切除。我们回顾了自1964年首次描述以来的47例类似病例,并评估了不同的诊断和治疗方法。淋巴管造影以前被认为是评估的金标准工具,现在由于高分辨率成像与抽吸技术的结合而不那么受欢迎。CTDC的治疗包括观察、低脂饮食、反复插管、外压、硬化治疗、栓塞和手术干预。迄今为止,首选的治疗方法是手术切除。
{"title":"Variations in the Management of Cervical Thoracic Duct Cyst.","authors":"Edgardo Abelardo,&nbsp;Priyanka Shastri,&nbsp;Vinod Prabhu","doi":"10.1159/000507275","DOIUrl":"https://doi.org/10.1159/000507275","url":null,"abstract":"<p><p>We present an uncomplicated case report of a cervical thoracic duct cyst (CTDC) in a 61-year-old woman treated with surgical excision. We reviewed 47 similar cases since it was first described in 1964 and evaluated the different diagnostic and management approaches. Previously believed to be the gold standard tool for evaluation, lymphangiography is now less popular due to advent of high-resolution imaging combined with aspiration techniques. CTDC treatment includes observation, low-fat diet, repeated aspirations, external pressure, sclerotherapy, embolisation, and surgical intervention. The preferred management of choice to date is surgical excision.</p>","PeriodicalId":9075,"journal":{"name":"Biomedicine Hub","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000507275","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38248294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Meningocele of the Internal Auditory Canal Requiring Facial-Nerve Decompression. 需要面神经减压的内耳道脑膜膨出。
Pub Date : 2020-05-11 eCollection Date: 2020-05-01 DOI: 10.1159/000507420
Jeffrey Liaw, Huseyin Isildak

In this case report, we present the case of a 14-month-old boy with a history of left facial palsy which developed at a very young age. CT of the temporal bone revealed a cystic lesion of the left petrous apex, and sedated auditory testing revealed a profound hearing loss on the same side. Following his first episode of left facial palsy, his symptoms nearly fully resolved and he was lost to follow-up. However, he was seen 5 months later due to recurrent and sudden left-sided facial paralysis. MRI was performed due to suspicion of an epidermoid cyst. The patient was subsequently taken to the operating room for facial-nerve decompression. Intraoperatively, no obvious cystic lesion was identified. Tissue biopsied from the internal auditory canal demonstrated benign glial tissue and fibrous tissue consistent with a meningocele.

在这个病例报告中,我们提出了一个14个月大的男孩在很小的时候就有左面瘫的病史。颞骨CT显示左侧岩尖囊性病变,镇静听力测试显示同侧重度听力损失。在他的第一次左面瘫发作后,他的症状几乎完全消失,他失去了随访。然而,5个月后,由于复发性和突发性左侧面瘫而就诊。怀疑为表皮样囊肿,行MRI检查。患者随后被送往手术室进行面神经减压术。术中未见明显囊性病变。内耳道组织活检显示良性胶质组织和纤维组织与脑膜膨出一致。
{"title":"Meningocele of the Internal Auditory Canal Requiring Facial-Nerve Decompression.","authors":"Jeffrey Liaw,&nbsp;Huseyin Isildak","doi":"10.1159/000507420","DOIUrl":"https://doi.org/10.1159/000507420","url":null,"abstract":"<p><p>In this case report, we present the case of a 14-month-old boy with a history of left facial palsy which developed at a very young age. CT of the temporal bone revealed a cystic lesion of the left petrous apex, and sedated auditory testing revealed a profound hearing loss on the same side. Following his first episode of left facial palsy, his symptoms nearly fully resolved and he was lost to follow-up. However, he was seen 5 months later due to recurrent and sudden left-sided facial paralysis. MRI was performed due to suspicion of an epidermoid cyst. The patient was subsequently taken to the operating room for facial-nerve decompression. Intraoperatively, no obvious cystic lesion was identified. Tissue biopsied from the internal auditory canal demonstrated benign glial tissue and fibrous tissue consistent with a meningocele.</p>","PeriodicalId":9075,"journal":{"name":"Biomedicine Hub","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000507420","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38256662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
In-Hospital Outcomes and Trends of Tricuspid Valve Surgery in Heart Transplant Patients. 心脏移植患者三尖瓣手术的住院结果和趋势。
Pub Date : 2020-04-17 eCollection Date: 2020-01-01 DOI: 10.1159/000507179
Moghniuddin Mohammed, Aniket S Rali, Tyler Buechler, Venkat Vuddanda, Juwairiya Arshi, Seyed Hamed Hosseini Dehkordi, Jonathan Chandler, Robert Weidling, Travis Abicht, Nicholas Haglund, Andrew Sauer, Zubair Shah

Introduction: Tricuspid valve (TV) regurgitation is the most common valvular pathology after orthotopic heart transplant (OHT). The number of transplants being performed is increasing with patients living longer after heart transplant. Data on TV surgery in OHT recipients is limited.

Methods: We sought to analyze the outcomes of patients undergoing TV surgery from a large diverse, multicentric, nationwide cohort using the Nationwide Inpatient Sample (NIS) database.

Results: A total of 42,766 TV repair or replacement (bioprosthetic and mechanical) involving adult patients (age ≥18 years) between 2007 and September 2015 were identified. Of these, 366 were performed in patients with OHT. TV repair was the most common surgery performed in both groups (OHT group and native heart group). Compared to the native group, patients with OHT had a significantly higher incidence of cardiogenic shock (20 vs. 11%, p = 0.024), acute kidney injury (AKI) (59 vs. 30%, p < 0.001), and AKI requiring hemodialysis (13 vs. 4%, p < 0.001). Also, the mean length of stay for the index admission was significantly longer in the OHT group (27 vs. 17 days, p = 0.008). The mortality rate was similar between the two groups (7 vs. 8%, p = 0.753). The number of TV surgeries performed in OHT patients from 2007 to 2014 have remained stable (p = 0.803) compared to those in native heart patients which showed a significantly increasing trend (p = 0.019) during the same time period.

Conclusions: TV surgery remains an important treatment modality among the OHT population and carries a similar mortality during index hospitalization as that in native heart patients undergoing TV surgery.

简介:三尖瓣反流是原位心脏移植术后最常见的瓣膜病理。随着患者心脏移植后寿命的延长,移植手术的数量也在增加。OHT受者的电视手术数据有限。方法:我们试图利用全国住院患者样本(NIS)数据库,从一个大型的、多样化的、多中心的全国队列中分析接受电视手术的患者的结果。结果:2007年至2015年9月,共有42,766例电视修复或置换术(生物假体和机械假体)涉及成年患者(年龄≥18岁)。其中,366例是在OHT患者中进行的。电视修复是两组(OHT组和原生心脏组)最常见的手术。与本地组相比,OHT患者的心源性休克发生率(20比11%,p = 0.024)、急性肾损伤(59比30%,p < 0.001)和需要血液透析的AKI发生率(13比4%,p < 0.001)明显更高。此外,OHT组的平均住院时间明显更长(27天vs. 17天,p = 0.008)。两组的死亡率相似(7% vs. 8%, p = 0.753)。2007 - 2014年,OHT患者的TV手术次数保持稳定(p = 0.803),而同期本土心脏病患者的TV手术次数呈显著上升趋势(p = 0.019)。结论:电视手术在OHT人群中仍然是一种重要的治疗方式,在指数住院期间的死亡率与接受电视手术的本土心脏病患者相似。
{"title":"In-Hospital Outcomes and Trends of Tricuspid Valve Surgery in Heart Transplant Patients.","authors":"Moghniuddin Mohammed,&nbsp;Aniket S Rali,&nbsp;Tyler Buechler,&nbsp;Venkat Vuddanda,&nbsp;Juwairiya Arshi,&nbsp;Seyed Hamed Hosseini Dehkordi,&nbsp;Jonathan Chandler,&nbsp;Robert Weidling,&nbsp;Travis Abicht,&nbsp;Nicholas Haglund,&nbsp;Andrew Sauer,&nbsp;Zubair Shah","doi":"10.1159/000507179","DOIUrl":"https://doi.org/10.1159/000507179","url":null,"abstract":"<p><strong>Introduction: </strong>Tricuspid valve (TV) regurgitation is the most common valvular pathology after orthotopic heart transplant (OHT). The number of transplants being performed is increasing with patients living longer after heart transplant. Data on TV surgery in OHT recipients is limited.</p><p><strong>Methods: </strong>We sought to analyze the outcomes of patients undergoing TV surgery from a large diverse, multicentric, nationwide cohort using the Nationwide Inpatient Sample (NIS) database.</p><p><strong>Results: </strong>A total of 42,766 TV repair or replacement (bioprosthetic and mechanical) involving adult patients (age ≥18 years) between 2007 and September 2015 were identified. Of these, 366 were performed in patients with OHT. TV repair was the most common surgery performed in both groups (OHT group and native heart group). Compared to the native group, patients with OHT had a significantly higher incidence of cardiogenic shock (20 vs. 11%, <i>p</i> = 0.024), acute kidney injury (AKI) (59 vs. 30%, <i>p</i> < 0.001), and AKI requiring hemodialysis (13 vs. 4%, <i>p</i> < 0.001). Also, the mean length of stay for the index admission was significantly longer in the OHT group (27 vs. 17 days, <i>p</i> = 0.008). The mortality rate was similar between the two groups (7 vs. 8%, <i>p</i> = 0.753). The number of TV surgeries performed in OHT patients from 2007 to 2014 have remained stable (<i>p</i> = 0.803) compared to those in native heart patients which showed a significantly increasing trend (<i>p</i> = 0.019) during the same time period.</p><p><strong>Conclusions: </strong>TV surgery remains an important treatment modality among the OHT population and carries a similar mortality during index hospitalization as that in native heart patients undergoing TV surgery.</p>","PeriodicalId":9075,"journal":{"name":"Biomedicine Hub","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000507179","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38248292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Differences in Responses on the Modified Clinical Test of Sensory Interaction and Balance on Medium Firm and Medium Density Foam in Healthy Controls and Patients with Vestibular Disorders. 健康对照者与前庭功能障碍患者对中硬、中密度泡沫感觉相互作用和平衡修正临床测试反应的差异
Pub Date : 2020-04-14 eCollection Date: 2020-01-01 DOI: 10.1159/000507180
Helen S Cohen, Haleh Sangi-Haghpeykar

Purpose: To determine whether foam density affects modified Romberg balance test performance.

Materials and methods: Controls and patients with vestibular disorders performed Romberg tests on medium and medium firm foam, with their eyes closed and the head still and moving in yaw and pitch. The trial duration and number of head movements were measured.

Results: Subjects aged >60 years performed longer and with more head movements on medium firm foam than on medium foam. Older controls did not differ between medium firm and medium foam. Older patients had higher scores on head-still and head-yaw trials on medium firm foam versus medium foam but pitch trials did not differ. Females, controls, and patients had longer trial durations and more head movements on medium firm foam than on medium density foam; male controls did not differ by foam density. Male patients differed in yaw trials.

Conclusion: Foam density affects scores. Clinical decision-making may be adversely affected if the clinician uses foam of a density that is not the same as that of the foam that was used in the studies that developed descriptive statistics, sensitivity, and specificity.

目的:确定泡沫密度是否影响修正Romberg平衡试验性能。材料和方法:对照组和前庭功能障碍患者闭上眼睛,头部静止、偏航和俯仰运动,对中、中硬泡沫进行Romberg试验。测量试验持续时间和头部运动次数。结果:年龄>60岁的受试者在使用中硬泡沫时比使用中硬泡沫时表现更长,头部运动更多。较老的对照组在中等硬度和中等泡沫之间没有差异。老年患者在中硬泡沫和中硬泡沫的头部静止和头部偏航试验中得分较高,但俯仰试验没有差异。与使用中密度泡沫相比,使用中等硬度泡沫的女性、对照组和患者的试验持续时间更长,头部运动更多;男性控制组的泡沫密度没有差异。男性患者在偏航试验中有所不同。结论:泡沫密度影响评分。如果临床医生使用的泡沫密度与开发描述性统计、敏感性和特异性的研究中使用的泡沫密度不同,则可能对临床决策产生不利影响。
{"title":"Differences in Responses on the Modified Clinical Test of Sensory Interaction and Balance on Medium Firm and Medium Density Foam in Healthy Controls and Patients with Vestibular Disorders.","authors":"Helen S Cohen,&nbsp;Haleh Sangi-Haghpeykar","doi":"10.1159/000507180","DOIUrl":"https://doi.org/10.1159/000507180","url":null,"abstract":"<p><strong>Purpose: </strong>To determine whether foam density affects modified Romberg balance test performance.</p><p><strong>Materials and methods: </strong>Controls and patients with vestibular disorders performed Romberg tests on medium and medium firm foam, with their eyes closed and the head still and moving in yaw and pitch. The trial duration and number of head movements were measured.</p><p><strong>Results: </strong>Subjects aged >60 years performed longer and with more head movements on medium firm foam than on medium foam. Older controls did not differ between medium firm and medium foam. Older patients had higher scores on head-still and head-yaw trials on medium firm foam versus medium foam but pitch trials did not differ. Females, controls, and patients had longer trial durations and more head movements on medium firm foam than on medium density foam; male controls did not differ by foam density. Male patients differed in yaw trials.</p><p><strong>Conclusion: </strong>Foam density affects scores. Clinical decision-making may be adversely affected if the clinician uses foam of a density that is not the same as that of the foam that was used in the studies that developed descriptive statistics, sensitivity, and specificity.</p>","PeriodicalId":9075,"journal":{"name":"Biomedicine Hub","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000507180","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38248293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
Biomedicine Hub
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1